Deciphera Pharmaceuticals (DCPH) Earnings
|
Expand Research on DCPH
| Next EPS Date | 11/8/23 | EPS Growth Rate | +54.7% |
|---|---|---|---|
| Average EPS % Beat Rate | -33.8% | Revenue Growth Rate | +62.8% |
| Average % Move 1-Wk after EPS | +3.4% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 11/8/23 | Q323 | N/A | -$0.62 | N/A | N/A | $37.8M | N/A | N/A | N/A | ||
| 8/3/23 | Q223 | N/A | -$0.62 | N/A | N/A | $36.1M | N/A | N/A | N/A | ||
| 8/9/23 | Q223 | -$0.57 | -$0.62 | +$0.05 | $38.3M | $36.1M | N/A |  | | Details | |
| 5/3/23 | Q123 | -$0.60 | -$0.59 | -$0.01 | $33.4M | $35.69M | N/A | | | Details | |
| 2/7/23 | Q422 | -$0.60 | -$0.57 | -$0.03 | $36.35M | $35.67M | N/A | | | Details | |
| 3/15/23 | Q422 | N/A | -$0.57 | N/A | N/A | $35.67M | N/A | N/A | N/A | ||
| 11/3/22 | Q322 | -$1.37 | -$0.58 | -$0.79 | $23.22M | $33.15M | N/A | | | Details | |
| 8/4/22 | Q222 | -$0.60 | -$0.66 | +$0.06 | $32.5M | $30.58M | N/A | | | Details |
